Owned by the Association for International Promotion & Study in Tumors (APSIT)
NOX1 inhibition attenuates the development of a pro‐tumorigenic environment in experimental hepatocellular carcinoma
The poor prognosis of advanced HCC and limited efficacy of current systemic treatments emphasize the need for new or combined targeted therapies. The development of HCC is a multistage process in which liver i...
Citation: Journal of Experimental & Clinical Cancer Research 2021 40:40